The tachykinin NK1 receptor in the brain: pharmacology and putative functions

This publication has 104 references indexed in Scilit:

• 2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N- methylamide (SDZ NKT 343), a Potent Human NK₁ Tachykinin Receptor Antagonist with Good Oral Analgesic Activity in Chronic Pain Models
  Journal of Medicinal Chemistry, 1998
• Anxiolytic Action of a Neurokinin1 Receptor Antagonist in the Social Interaction Test
  Pharmacology Biochemistry and Behavior, 1997
• The non-pfjptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs
  Life Sciences, 1997
• Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets
  Neuropharmacology, 1996
• NK1 receptor expression by cholinergic interneurones in human striatum
  NeuroReport, 1994
• Immunocytochemical localization of rat substance P receptor in the striatum
  Neuroscience Letters, 1993
• Molecular cloning of the murine substance K and substance P receptor genes
  European Journal of Biochemistry, 1992
• Pharmacological receptors for substance P and neurokinins
  Life Sciences, 1987
• Substance P and Parkinson's disease: a causal relationship?
  Journal of Theoretical Biology, 1986
• A substance P antagonist inhibits heat-induced oedema in the rat skin
  Acta Physiologica Scandinavica, 1984